| [1] |
张兴龙, 蔡林, 朱称心, 等. 内镜检查在结直肠癌防治中的应用及研究进展[J]. 肿瘤学杂志, 2024, 30(10): 825-832.
|
| [2] |
Knudsen AB, Rutter CM, Peterse EFP, et al. Colorectal cancer screening: an updated modeling study for the US preventive services task force[J]. JAMA, 2021, 325(19): 1998-2011.
|
| [3] |
Gupta S, Lieberman D, Anderson J C, et al. Recommendations for follow-up after colonoscopy and polypectomy: a consensus update by the US multi-society task force on colorectal cancer[J]. Am J Gastroenterol, 2020, 115(3): 415-434.
|
| [4] |
上海国家消化系统疾病临床医学研究中心(上海), 中华医学会消化内镜学分会, 中国抗癌协会肿瘤内镜专业委员会, 等. 中国结直肠癌癌前病变和癌前状态处理策略专家共识[J]. 中华消化内镜杂志, 2022, 39(1): 1-18.
|
| [5] |
Sint Nicolaas J, de Jonge V, van Baalen O, et al. Optimal resource allocation in colonoscopy: timing of follow-up colonoscopies in relation to adenoma detection rates[J]. Endoscopy, 2013, 45(7): 545-552.
|
| [6] |
Song M, Garrett WS, Chan AT. Nutrients, foods, and colorectal cancer prevention[J]. Gastroenterology, 2015, 148(6): 1244-1260.
|
| [7] |
Ma Z, Zou S, Liu R, et al. Socioeconomic development index (SDI) gradients and high BMI-Driven pan-cancer burden: a global burden of disease study on mortality, disability, and health inequities (2015-2021)[J]. BMC Public Health, 2025, 25(1): 3295.
|
| [8] |
Vahed IE, Esmaili Z, Mamaghani MP, et al. The association between serum lipid levels and colorectal cancer risk: a dose-response meta-analysis of 23 studies[J]. PloS One, 2025, 20(10): e0333907.
|
| [9] |
Zhou X, Sevilla-Gonzalez M, Phipps AI, et al. Diabetogenic processes for insulin resistance-linked hyperinsulinaemia are associated with colorectal cancer[J]. Diabetologia, 2026, 69(4): 942-952.
|
| [10] |
王树玲, 康争春, 赵胜兵, 等. 加强结肠镜检查规范培训, 提高结肠腺瘤检出率[J]. 海军军医大学学报, 2023, 44(3): 265-271.
|
| [11] |
何晋德, 王怀堂, 刘玉兰, 等. 常规电子结肠镜检查中结肠息肉漏诊分析[J]. 中华消化内镜杂志, 2007, 24(5): 354-356.
|
| [12] |
崔璐, 乔伟光, 朱博, 等. 内镜反转技术对右半结肠息肉检出率影响的研究[J]. 现代消化及介入诊疗, 2017, 22(2): 238-240.
|
| [13] |
中国肥胖问题工作组. 中国成人超重和肥胖症预防与控制指南(节录)[J]. 营养学报, 2004, (1): 1-4.
|
| [14] |
王增武, 刘静, 李建军, 等. 中国血脂管理指南(2023年)[J]. 中国循环杂志, 2023, 38(3): 237-271.
|
| [15] |
Tomayko MM, Reynolds CP. Determination of subcutaneous tumor size in athymic (nude) mice[J]. Cancer Chemotherapy and Pharmacology, 1989, 24(3): 148-154.
|
| [16] |
Liu Y, Cheng C, Li W, et al. Machine learning-based prediction of short-term recurrence of colorectal adenomatous polyps following EMR: model development and validation study[J]. Int J Med Inform, 2026, 206: 106165.
|
| [17] |
Stoian M, Becheanu G, Balescu I, et al. Recurrence and carcinogenetic rates of colorectal polyps[J]. Chirurgia (Bucur), 2024, 119(1): 21-35.
|
| [18] |
Kasugai K, Ogasawara N, Sasaki M. Colonoscopy surveillance after polypectomy[J]. Clin J Gastroenterol, 2011, 4(6): 355-363.
|
| [19] |
Du JY, Huang GY, Xie YC, et al. High levels of triglycerides, apolipoprotein B, and the number of colorectal polyps are risk factors for colorectal polyp recurrence after endoscopic resection: a retrospective study[J]. J Gastrointest Oncol, 2022, 13(4): 1753-1760.
|
| [20] |
Du M, Drew DA, Goncalves MD, et al. Early-onset colorectal cancer as an emerging disease of metabolic dysregulation[J]. Nature Reviews Endocrinology, 2025, 21(11): 686-702.
|
| [21] |
Du Q, Wang Q, Fan H, et al. Dietary cholesterol promotes AOM-induced colorectal cancer through activating the NLRP3 inflammasome[J]. Biochemical pharmacology, 2016, 105: 42-54.
|
| [22] |
Zhang L, Xiao G, Su D, et al. Diagnostic value of the combined detection of microbiota, multiple inflammation-related indicators, serum lipid indices, and tumour markers in colorectal polyps: a case-control study[J]. Int J Med Sci, 2025, 22(11): 2757-2770.
|
| [23] |
Tian Y, Wang K, Li J, et al. The association between serum lipids and colorectal neoplasm: a systemic review and meta-analysis[J]. Public Health Nutrition, 2015, 18(18): 3355-3370.
|
| [24] |
Zhang L, Feng Z, Li Y, et al. Salivary and fecal microbiota: potential new biomarkers for early screening of colorectal polyps[J]. Front Microbiol, 2023, 14: 1182346.
|
| [25] |
Ren Y, Zhuang Z, Xie Y, et al. BCAA-producing clostridium symbiosum promotes colorectal tumorigenesis through the modulation of host cholesterol metabolism[J]. Cell Host & Microbe, 2024, 32(9): 1519-1535.
|
| [26] |
Xie X, Wang W, Zhang H, et al. Cholesterol-induced colorectal cancer progression and its mitigation through gut microbiota remodeling and simvastatin treatment[J]. BMC Cancer, 2025, 25(1): 977.
|
| [27] |
Ben Q, An W, Jiang Y, et al. Body mass index increases risk for colorectal adenomas based on meta-analysis[J]. Gastroenterology, 2012, 142(4): 762-772.
|
| [28] |
Yam ST, Mclauchlan J, Mccombie A, et al. Colorectal polyp distribution in relation to age: meta-analysis[J]. BJS Open, 2025, 9(6): zraf132.
|
| [29] |
薛露露, 杨桢, 赵亚涛. 45~54岁无症状体检者结直肠镜筛查情况分析[J]. 肿瘤基础与临床, 2025, 38(4): 555-557.
|